Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010 (2010), Article ID 359732, 18 pages
http://dx.doi.org/10.1155/2010/359732
Review Article

Role of Heme Oxygenase in Inflammation, Insulin-Signalling, Diabetes and Obesity

Department of Physiology, College of Medicine, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK, Canada S7N 5E5

Received 12 December 2009; Revised 15 February 2010; Accepted 24 February 2010

Academic Editor: Giuseppe Matarese

Copyright © 2010 Joseph Fomusi Ndisang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Roglic, N. Unwin, P. H. Bennett et al., “The burden of mortality attributable to diabetes: realistic estimates for the year 2000,” Diabetes Care, vol. 28, no. 9, pp. 2130–2135, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. McCredie, “Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998–2002,” Nephrology Dialysis Transplantation, vol. 21, no. 8, pp. 2178–2183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. W. J. Millar and T. K. Young, “Tracking diabetes: prevalence, incidence and risk factors,” Health Reports, vol. 14, no. 3, pp. 35–47, 2003. View at Google Scholar
  5. S. Bleich, D. Cutler, C. Murray, and A. Adams, “Why is the developed world obese?” Annual Review of Public Health, vol. 29, pp. 273–295, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Nagao and T. Yanagita, “Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome,” Pharmacological Research, vol. 61, no. 3, pp. 208–212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler, “β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes,” Diabetes, vol. 52, no. 1, pp. 102–110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. H. Israili, “Advances in the treatment of type 2 diabetes mellitus,” American Journal of Therapeutics. In press. View at Publisher · View at Google Scholar
  9. E. Cerasi and R. Luft, “Insulin response to glucose infusion in diabetic and non-diabetic monozygotic twin pairs. Genetic control of insulin response?” Acta Endocrinologica, vol. 55, no. 2, pp. 330–345, 1967. View at Google Scholar · View at Scopus
  10. P. Dantonio, N. Meredith, M. Earley et al., “A screening system for detecting genetic risk markers of type 1 diabetes in dried blood spots,” Diabetes Technology and Therapeutics, vol. 8, no. 4, pp. 433–443, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. J. Meier, A. Bhushan, A. E. Butler, R. A. Rizza, and P. C. Butler, “Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?” Diabetologia, vol. 48, no. 11, pp. 2221–2228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Liuwantara, M. Elliot, M. W. Smith et al., “Nuclear factor-?B regulates ß-cell death: a critical role for A20 in ß-cell protection,” Diabetes, vol. 55, no. 9, pp. 2491–2501, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. D. McKenzie, E. M. Carrington, T. Kaufmann et al., “Proapoptotic BH3-only protein bid is essential for death receptor-induced apoptosis of pancreatic ß-cells,” Diabetes, vol. 57, no. 5, pp. 1284–1292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Y. Donath, D. M. Schumann, M. Faulenbach, H. Ellingsgaard, A. Perren, and J. A. Ehses, “Islet inflammation in type 2 diabetes: from metabolic stress to therapy,” Diabetes Care, vol. 31, supplement 2, pp. S161–S164, 2008. View at Google Scholar · View at Scopus
  15. S. S. Vukkadapu, J. M. Belli, K. Ishii et al., “Dynamic interaction between T cell-mediated ß-cell damage and ß-cell repair in the run up to autoimmune diabetes of the NOD mouse,” Physiological Genomics, vol. 21, pp. 201–211, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. R. N. Bergman, D. T. Finegood, and S. E. Kahn, “The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes,” European Journal of Clinical Investigation, vol. 32, supplement 3, pp. 35–45, 2002. View at Google Scholar
  17. G. S. Dave and K. Kalia, “Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy,” Cellular and Molecular Biology, vol. 53, no. 5, pp. 68–78, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. G. L. King and M. R. Loeken, “Hyperglycemia-induced oxidative stress in diabetic complications,” Histochemistry and Cell Biology, vol. 122, no. 4, pp. 333–338, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Calderon, A. Suri, and E. R. Unanue, “In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet β-cell killing: studies from an acute model,” American Journal of Pathology, vol. 169, no. 6, pp. 2137–2147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Winer, H. Tsui, A. Lau et al., “Autoimmune islet destruction in spontaneous type 1 diabetes is not ß-cell exclusive,” Nature Medicine, vol. 9, no. 2, pp. 198–205, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Cnop, N. Welsh, J.-C. Jonas, A. Jörns, S. Lenzen, and D. L. Eizirik, “Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities,” Diabetes, vol. 54, supplement 2, pp. S97–S107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. D. Johnson, N. T. Ahmed, D. S. Luciani et al., “Increased islet apoptosis in Pdx1+/- mice,” Journal of Clinical Investigation, vol. 111, no. 8, pp. 1147–1160, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Bonner-Weir, “β-cell turnover: its assessment and implications,” Diabetes, vol. 50, supplement 1, pp. S20–S24, 2001. View at Google Scholar · View at Scopus
  24. M. Ridderstrale and L. Groop, “Genetic dissection of type 2 diabetes,” Molecular and Cellular Endocrinology, vol. 297, no. 1-2, pp. 10–17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Feinstein, H. Kanety, M. Z. Papa, B. Lunenfeld, and A. Karasik, “Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates,” The Journal of Biological Chemistry, vol. 268, no. 35, pp. 26055–26058, 1993. View at Google Scholar · View at Scopus
  26. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, “Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance,” Science, vol. 259, no. 5091, pp. 87–91, 1993. View at Google Scholar · View at Scopus
  27. G. S. Hotamisligil and B. M. Spiegelman, “Tumor necrosis factor α: a key component of the obesity-diabetes link,” Diabetes, vol. 43, no. 11, pp. 1271–1278, 1994. View at Google Scholar
  28. K. T. Uysal, S. M. Wiesbrock, M. W. Marino, and G. S. Hotamisligil, “Protection from obesity-induced insulin resistance in mice lacking TNF-α function,” Nature, vol. 389, no. 6651, pp. 610–614, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. K. P. Karalis, P. Giannogonas, E. Kodela, Y. Koutmani, M. Zoumakis, and T. Teli, “Mechanisms of obesity and related pathology: linking immune responses to metabolic stress,” FEBS Journal, vol. 276, no. 20, pp. 5747–5754, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Fernández-Veledo, R. Vila-Bedmar, I. Nieto-Vazquez, and M. Lorenzo, “c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-α induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3583–3593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Tuncman, J. Hirosumi, G. Solinas, L. Chang, M. Karin, and G. S. Hotamisligil, “Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 28, pp. 10741–10746, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Tilg and A. R. Moschen, “Inflammatory mechanisms in the regulation of insulin resistance,” Molecular Medicine, vol. 14, no. 3-4, pp. 222–231, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. P. A. Permana, C. Menge, and P. D. Reaven, “Macrophage-secreted factors induce adipocyte inflammation and insulin resistance,” Biochemical and Biophysical Research Communications, vol. 341, no. 2, pp. 507–514, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Sabio, M. Das, A. Mora et al., “A stress signaling pathway in adipose tissue regulates hepatic insulin resistance,” Science, vol. 322, no. 5907, pp. 1539–1543, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Scazzocchio, R. Varì, M. D'Archivio et al., “Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases,” Journal of Lipid Research, vol. 50, no. 5, pp. 832–845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Y. Donath, M. Boni-Schnetzler, H. Ellingsgaard, and J. A. Ehses, “Islet inflammation impairs the pancreatic B-ceII in type 2 diabetes,” Physiology, vol. 24, no. 6, pp. 325–331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. G. S. Hotamisligil, “Inflammation and metabolic disorders,” Nature, vol. 444, no. 7121, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Mosén, A. Salehi, P. Alm et al., “Defective glucose-stimulated insulin release in the diabetic Goto-Kakizaki (GK) rat coincides with reduced activity of the islet carbon monoxide signaling pathway,” Endocrinology, vol. 146, no. 3, pp. 1553–1558, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. C. R. Bruce, A. L. Carey, J. A. Hawley, and M. A. Febbraio, “Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism,” Diabetes, vol. 52, no. 9, pp. 2338–2345, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Li, D. H. Kim, P. L. Tsenovoy et al., “Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance,” Diabetes, vol. 57, no. 6, pp. 1526–1535, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. J. F. Ndisang and A. Jadhav, “Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes,” American Journal of Physiology, vol. 296, no. 4, pp. E829–E841, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. J. F. Ndisang and A. Jadhav, “Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats,” Endocrinology, vol. 150, no. 6, pp. 2627–2636, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. J. F. Ndisang, N. Lane, and A. Jadhav, “The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways,” Endocrinology, vol. 150, no. 5, pp. 2098–2108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. J. F. Ndisang, N. Lane, and A. Jadhav, “Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes,” American Journal of Physiology, vol. 296, no. 5, pp. E1029–E1041, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Mosén, A. Salehi, R. Henningsson, and I. Lundquist, “Nitric oxide inhibits, and carbon monoxide activates, islets acid α-glucoside hydrolase activities in parallel with glucose-stimulated insulin secretion,” Journal of Endocrinology, vol. 190, no. 3, pp. 681–693, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Henningsson, P. Alm, P. Ekström, and I. Lundquist, “Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study,” Diabetes, vol. 48, no. 1, pp. 66–76, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. J. F. Ndisang, N. Lane, N. Syed, and A. Jadhav, “Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats,” Endocrinology, vol. 151, no. 2, pp. 549–560, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. J. F. Ndisang and A. Jadhav, “The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension,” American Journal of Physiology, vol. 298, no. 1, pp. R211–R223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. I. Lundquist, P. Alm, A. Salehi, R. Henningsson, E. Grapengiesser, and B. Hellman, “Carbon monoxide stimulates insulin release and propagates Ca2+ signals between pancreatic β-cells,” American Journal of Physiology, vol. 285, no. 5, pp. E1055–E1063, 2003. View at Google Scholar · View at Scopus
  50. N. Welsh and S. Sandler, “Protective action by hemin against interleukin-1β induced inhibition of rat pancreatic islet function,” Molecular and Cellular Endocrinology, vol. 103, no. 1-2, pp. 109–114, 1994. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Henningsson, P. Alm, and I. Lundquist, “Occurrence and putative hormone regulatory function of a constitutive heme oxygenase in rat pancreatic islets,” American Journal of Physiology, vol. 273, no. 2, pp. C703–C709, 1997. View at Google Scholar · View at Scopus
  52. J. Ye and S. G. Laychock, “A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1β,” Endocrinology, vol. 139, no. 10, pp. 4155–4163, 1998. View at Google Scholar · View at Scopus
  53. J. D. Dimitrov, S. Dasgupta, A. M. Navarrete et al., “Induction of heme oxygenase-1 in factor VIII-deficient mice reduces the immune response to therapeutic factor VIII,” Blood, vol. 115, no. 13, pp. 2682–2685, 2010. View at Google Scholar
  54. S. Tzima, P. Victoratos, K. Kranidioti, M. Alexiou, and G. Kollias, “Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-β production,” Journal of Experimental Medicine, vol. 206, no. 5, pp. 1167–1179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. C. Mirabella, R. Baronti, L. A. Berni et al., “Hemin and carbon monoxide modulate the immunological response of human basophils,” International Archives of Allergy and Immunology, vol. 118, no. 2–4, pp. 259–260, 1999. View at Google Scholar · View at Scopus
  56. J. F. Ndisang, R. Wang, A. Vannacci et al., “Haeme oxygenase-1 and cardiac anaphylaxis,” British Journal of Pharmacology, vol. 134, no. 8, pp. 1689–1696, 2001. View at Google Scholar · View at Scopus
  57. L. Bellner, L. Martinelli, A. Halilovic et al., “Heme oxygenase-2 deletion causes endothelial cell activation marked by oxidative stress, inflammation, and angiogenesis,” Journal of Pharmacology and Experimental Therapeutics, vol. 331, no. 3, pp. 925–932, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. N. G. Abraham and A. Kappas, “Pharmacological and clinical aspects of heme oxygenase,” Pharmacological Reviews, vol. 60, no. 1, pp. 79–127, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. J. F. Ndisang, H. E. N. Tabien, and R. Wang, “Carbon monoxide and hypertension,” Journal of Hypertension, vol. 22, no. 6, pp. 1057–1074, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. J. F. Ndisang, P. Gai, L. Berni et al., “Modulation of the immunological response of guinea pig mast cells by carbon monoxide,” Immunopharmacology, vol. 43, no. 1, pp. 65–73, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. J. F. Ndisang and A. Jadhav, “Upregulating the heme oxygenase system suppresses left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months,” Journal of Cardiac Failure, vol. 15, no. 7, pp. 616–628, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. J. F. Ndisang, M. Moncini, P. Gai et al., “Induction of heme oxygenaase provides protection against cardiac anaphylaxis,” Inflammation Research, vol. 49, supplement 1, pp. S76–S77, 2000. View at Google Scholar · View at Scopus
  63. J. F. Ndisang, L. Wu, W. Zhao, and R. Wang, “Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats,” Blood, vol. 101, no. 10, pp. 3893–3900, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. J. F. Ndisang, W. Zhao, and R. Wang, “Selective regulation of blood pressure by heme oxygenase-1 in hypertension,” Hypertension, vol. 40, no. 3, pp. 315–321, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Jadhav, E. Torlakovic, and J. F. Ndisang, “Interaction among heme oxygenase, nuclear factor-κB, and transcription activating factors in cardiac hypertrophy in hypertension,” Hypertension, vol. 52, no. 5, pp. 910–917, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. D. E. Baranano, M. Rao, C. D. Ferris, and S. H. Snyder, “Biliverdin reductase: a major physiologic cytoprotectant,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 25, pp. 16093–16098, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. R. Stocker, A. N. Glazer, and B. N. Ames, “Antioxidant activity of albumin-bound bilirubin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 16, pp. 5918–5922, 1987. View at Google Scholar · View at Scopus
  68. R. Stocker, Y. Yamamoto, A. F. McDonagh, A. N. Glazer, and B. N. Ames, “Bilirubin is an antioxidant of possible physiological importance,” Science, vol. 235, no. 4792, pp. 1043–1046, 1987. View at Google Scholar · View at Scopus
  69. S. A. Bainbridge, L. Belkacemi, M. Dickinson, C. H. Graham, and G. N. Smith, “Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast,” American Journal of Pathology, vol. 169, no. 3, pp. 774–783, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. G. Balla, H. S. Jacob, J. Balla et al., “Ferritin: a cytoprotective antioxidant strategem of endothelium,” The Journal of Biological Chemistry, vol. 267, no. 25, pp. 18148–18153, 1992. View at Google Scholar · View at Scopus
  71. K. J. Hintze and E. C. Theil, “DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 42, pp. 15048–15052, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Zhuang, Y.-S. Kim, K. Namiranian, and S. Doré, “Prostaglandins of J series control heme oxygenase expression: potential significance in modulating neuroinflammation,” Annals of the New York Academy of Sciences, vol. 993, pp. 208–216, 2003. View at Google Scholar · View at Scopus
  73. Y.-S. Kim, H. Zhuang, R. C. Koehler, and S. Doré, “Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity,” Free Radical Biology and Medicine, vol. 38, no. 1, pp. 85–92, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. W. K. McCoubrey Jr., J. F. Ewing, and M. D. Maines, “Human heme oxygenase-2: characterization and expression of a full-length cDNA and evidence suggesting that the two HO-2 transcripts may differ by choice of polyadenylation signal,” Archives of Biochemistry and Biophysics, vol. 295, no. 1, pp. 13–20, 1992. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Hayashi, Y. Omata, H. Sakamoto et al., “Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene,” Gene, vol. 336, no. 2, pp. 241–250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. N. G. Abraham, H. Jiang, M. Balazy, and A. I. Goodman, “Methods for measurements of heme oxygenase (HO) isoforms-mediated synthesis of carbon monoxide and HO-1 and HO-2 proteins,” Methods in Molecular Medicine, vol. 86, pp. 399–411, 2003. View at Google Scholar · View at Scopus
  77. S. M. Keyse and R. M. Tyrrell, “Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 1, pp. 99–103, 1989. View at Google Scholar · View at Scopus
  78. Y. Wei, X.-M. Liu, K. J. Peyton et al., “Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival,” American Journal of Physiology, vol. 297, no. 4, pp. C907–C915, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. T. Mohri, H. Ogura, T. Koh et al., “Enhanced expression of intracellular heme oxygenase-1 in deactivated monocytes from patients with severe systemic inflammatory response syndrome,” Journal of Trauma: Injury, Infection and Critical Care, vol. 61, no. 3, pp. 616–623, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. J. C. Jonas, Y. Guiot, J. Rahier, and J. C. Henquin, “Haeme-oxygenase 1 expression in rat pancreatic beta cells is stimulated by supraphysiological glucose concentrations and by cyclic AMP,” Diabetologia, vol. 46, no. 9, pp. 1234–1244, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Landar, J. W. Zmijewski, D. A. Dickinson et al., “Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species,” American Journal of Physiology, vol. 290, no. 5, pp. H1777–H1787, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. J. F. Ndisang, P. F. Mannaioni, and R. Wang, “Carbon monoxide and cardiovascular inflammation,” in Carbon Monoxide and Cardiovascular Functions, R. Wang, Ed., pp. 165–180, CPC Press, Boca Raton, Fla, USA, 2002. View at Google Scholar
  83. J. F. Ndisang and A. Jadhav, “Upregulating the heme oxygenase system suppresses left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months,” Journal of Cardiac Failure, vol. 15, no. 7, pp. 616–628, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. J. F. Ndisang, N. Lane, and A. Jadhav, “Crosstalk between the heme oxygenase system, aldosterone, and phospholipase C in hypertension,” Journal of Hypertension, vol. 26, no. 6, pp. 1188–1199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. J. F. Ndisang and R. Wang, “Alterations in heme oxygenase/carbon monoxide system in pulmonary arteries in hypertension,” Experimental Biology and Medicine, vol. 228, no. 5, pp. 557–563, 2003. View at Google Scholar · View at Scopus
  86. B. R.-S. Hsu, S.-T. Chen, and S.-H. Fu, “A single-dose of cobalt-protoporphyrin protects islet beta cells from glucocorticoid suppression,” Transplantation Proceedings, vol. 37, no. 4, pp. 1826–1827, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. S.-H. Fu, B. R.-S. Hsu, J.-H. Juang, S.-T. Chen, T.-Y. Yang, and S. Hsu, “Cobalt-protoporphyrin treatment enhances murine isoislets engraftment,” Transplantation Proceedings, vol. 36, no. 7, pp. 2205–2206, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. C. A. Piantadosi, “Biological chemistry of carbon monoxide,” Antioxidants and Redox Signaling, vol. 4, no. 2, pp. 259–270, 2002. View at Google Scholar · View at Scopus
  89. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. U. Özcan, Q. Cao, E. Yilmaz et al., “Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes,” Science, vol. 306, no. 5695, pp. 457–461, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. G. S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M. F. White, and B. M. Spiegelman, “IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance,” Science, vol. 271, no. 5249, pp. 665–668, 1996. View at Google Scholar · View at Scopus
  92. R. J. Davis, “Signal transduction by the JNK group of MAP kinases,” Cell, vol. 103, no. 2, pp. 239–252, 2000. View at Google Scholar · View at Scopus
  93. G. S. Hotamisligil, A. Budavari, D. Murray, and B. M. Spiegelman, “Reduced tyrosine kinase activity of the insulin receptor in obesity- diabetes. Central role of tumor necrosis factor-α,” Journal of Clinical Investigation, vol. 94, no. 4, pp. 1543–1549, 1994. View at Google Scholar · View at Scopus
  94. P. J. Klover, A. H. Clementi, and R. A. Mooney, “Interleukin-6 depletion selectively improves hepatic insulin action in obesity,” Endocrinology, vol. 146, no. 8, pp. 3417–3427, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. P. J. Klover, T. A. Zimmers, L. G. Koniaris, and R. A. Mooney, “Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice,” Diabetes, vol. 52, no. 11, pp. 2784–2789, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. T. Kanemaki, H. Kitade, M. Kaibori et al., “Interleukin 1ß and interleukin 6, but not tumor necrosis factor a, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes,” Hepatology, vol. 27, no. 5, pp. 1296–1303, 1998. View at Publisher · View at Google Scholar · View at Scopus
  97. L.-J. Ma, S.-L. Mao, K. L. Taylor et al., “Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1,” Diabetes, vol. 53, no. 2, pp. 336–346, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. X. Li, Y. Meng, P. Wu, Z. Zhang, and X. Yang, “Angiotensin II and Aldosterone stimulating NF-κB and AP-1 activation in hepatic fibrosis of rat,” Regulatory Peptides, vol. 138, no. 1, pp. 15–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. H. Otani, F. Otsuka, K. Inagaki et al., “Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation,” American Journal of Physiology, vol. 292, no. 5, pp. F1513–F1525, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. H. Kaneto, Y. Nakatani, D. Kawamori et al., “Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic ß-cell dysfunction and insulin resistance,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 5-6, pp. 782–793, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. B. L. Bennett, Y. Satoh, and A. J. Lewis, “JNK: a new therapeutic target for diabetes,” Current Opinion in Pharmacology, vol. 3, no. 4, pp. 420–425, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Kamigaki, S. Sakaue, I. Tsujino et al., “Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes,” Biochemical and Biophysical Research Communications, vol. 339, no. 2, pp. 624–632, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. U. M. Florczyk, A. Jozkowicz, and J. Dulak, “Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance,” Pharmacological Reports, vol. 60, no. 1, pp. 38–48, 2008. View at Google Scholar · View at Scopus
  104. C. Mirabella, J. F. Ndisang, L. A. Berni, P. Gai, E. Masini, and P. F. Mannaioni, “Modulation of the immunological activation of human basophils by carbon monoxide,” Inflammation Research, vol. 48, supplement 1, pp. S11–S12, 1999. View at Google Scholar · View at Scopus
  105. J. F. Ndisang, P. Gai, L. Berni et al., “Modulation of the immunological response of guinea pig mast cells by carbon monoxide,” Immunopharmacology, vol. 43, no. 1, pp. 65–73, 1999. View at Publisher · View at Google Scholar · View at Scopus
  106. J. McDaid, K. Yamashita, A. Chora et al., “Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells,” FASEB Journal, vol. 19, no. 3, pp. 458–460, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. M. P. Soares and F. H. Bach, “Heme oxygenase-1 in organ transplantation,” Frontiers in Bioscience, vol. 12, pp. 4932–4945, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. L. F. Rodella, L. Vanella, S. J. Peterson et al., “Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes,” Drug Metabolism Letters, vol. 2, no. 4, pp. 290–300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. J. Cao, G. Drummond, K. Inoue, K. Sodhi, X. Y. Li, and S. Omura, “Upregulation of heme oxygenase-1 combined with increased adiponectin lowers blood pressure in diabetic spontaneously hypertensive rats through a reduction in endothelial cell dysfunction, apoptosis and oxidative stress,” International Journal of Molecular Sciences, vol. 9, no. 12, pp. 2388–2406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. K. Sodhi, K. Inoue, K. H. Gotlinger et al., “Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 331, no. 3, pp. 906–916, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Nicolai, M. Li, D. H. Kim et al., “Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats,” Hypertension, vol. 53, no. 3, pp. 508–515, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. H. K. Dong, A. P. Burgess, M. Li et al., “Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-a and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 325, no. 3, pp. 833–840, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. S. J. Peterson, G. Drummond, D. H. Kim et al., “L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice,” Journal of Lipid Research, vol. 49, no. 8, pp. 1658–1669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. S. E. Shoelson, L. Herrero, and A. Naaz, “Obesity, inflammation, and insulin resistance,” Gastroenterology, vol. 132, no. 6, pp. 2169–2180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. F. Magkos and L. S. Sidossis, “Recent advances in the measurement of adiponectin isoform distribution,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 10, no. 5, pp. 571–575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. G. R. Steinberg, M. J. Watt, and M. A. Febbraio, “Cytokine Regulation of AMPK signalling,” Frontiers in Bioscience, vol. 14, pp. 1902–1916, 2009. View at Google Scholar · View at Scopus
  117. T. Yamauchi and T. Kadowaki, “Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases,” International Journal of Obesity, vol. 32, supplement 7, pp. S13–S18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  118. T. Yamauchi, J. Kamon, H. Waki et al., “Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis,” The Journal of Biological Chemistry, vol. 278, no. 4, pp. 2461–2468, 2003. View at Publisher · View at Google Scholar · View at Scopus
  119. M. Haluzik, “Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance,” Current Opinion in Investigational Drugs, vol. 6, no. 10, pp. 988–993, 2005. View at Google Scholar · View at Scopus
  120. N. Kubota, Y. Terauchi, T. Yamauchi et al., “Disruption of adiponectin causes insulin resistance and neointimal formation,” The Journal of Biological Chemistry, vol. 277, no. 29, pp. 25863–25866, 2002. View at Publisher · View at Google Scholar · View at Scopus
  121. C. J. Lyon, R. E. Law, and W. A. Hsueh, “Minireview: adiposity, inflammation, and atherogenesis,” Endocrinology, vol. 144, no. 6, pp. 2195–2200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  122. B. J. Goldstein and R. Scalia, “Adiponectin: a novel adipokine linking adipocytes and vascular function,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2563–2568, 2004. View at Publisher · View at Google Scholar · View at Scopus
  123. D. Yavuz, M. Koc, A. Toprak et al., “Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 4, no. 3, pp. 197–203, 2003. View at Google Scholar · View at Scopus
  124. M. A. G. Essers, L. M. M. de Vries-Smits, N. Barker, P. E. Polderman, B. M. T. Burgering, and H. C. Korswagen, “Functional interaction between β-catenin and FOXO in oxidative stress signaling,” Science, vol. 308, no. 5725, pp. 1181–1184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Yuan, N. Konstantopoulos, J. Lee et al., “Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkß,” Science, vol. 293, no. 5535, pp. 1673–1677, 2001. View at Publisher · View at Google Scholar · View at Scopus
  126. D. Cai, M. Yuan, D. F. Frantz et al., “Local and systemic insulin resistance resulting from hepatic activation of IKK-ß and NF-?B,” Nature Medicine, vol. 11, no. 2, pp. 183–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  127. D. Cai, J. D. Frantz, N. E. Tawa Jr. et al., “IKKß/NF-?B activation causes severe muscle wasting in mice,” Cell, vol. 119, no. 2, pp. 285–298, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. J. K. Kim, Y.-J. Kim, J. J. Fillmore et al., “Prevention of fat-induced insulin resistance by salicylate,” Journal of Clinical Investigation, vol. 108, no. 3, pp. 437–446, 2001. View at Publisher · View at Google Scholar · View at Scopus
  129. B. A. Bhatt, J. J. Dube, N. Dedousis, J. A. Reider, and R. M. O'Doherty, “Diet-induced obesity and acute hyperlipidemia reduce IκBα levels in rat skeletal muscle in a fiber-type dependent manner,” American Journal of Physiology, vol. 290, no. 1, pp. R233–R240, 2006. View at Publisher · View at Google Scholar · View at Scopus
  130. G. E. Sonnenberg, G. R. Krakower, and A. H. Kissebah, “A novel pathway to the manifestations of metabolic syndrome,” Obesity Research, vol. 12, no. 2, pp. 180–186, 2004. View at Google Scholar · View at Scopus
  131. A. G. Pittas, N. A. Joseph, and A. S. Greenberg, “Adipocytokines and insulin resistance,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 2, pp. 447–452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  132. W. A. Hsueh and M. J. Quiñones, “Role of endothelial dysfunction in insulin resistance,” The American Journal of Cardiology, vol. 92, no. 4, pp. 10J–17J, 2003. View at Google Scholar
  133. N. Ouchi, S. Kihara, T. Funahashi, Y. Matsuzawa, and K. Walsh, “Obesity, adiponectin and vascular inflammatory disease,” Current Opinion in Lipidology, vol. 14, no. 6, pp. 561–566, 2003. View at Publisher · View at Google Scholar · View at Scopus
  134. J. R. Sowers, “Obesity as a cardiovascular risk factor,” American Journal of Medicine, vol. 115, no. 8, supplement 1, pp. S37–S41, 2003. View at Publisher · View at Google Scholar · View at Scopus
  135. G. Reaven, F. Abbasi, and T. McLaughlin, “Obesity, insulin resistance, and cardiovascular disease,” Recent Progress in Hormone Research, vol. 59, pp. 207–223, 2004. View at Publisher · View at Google Scholar · View at Scopus
  136. D. T. Finegood, M. D. McArthur, D. Kojwang et al., “ß-cell mass dynamics in Zucker diabetic fatty rats: rosiglitazone prevents the rise in net cell death,” Diabetes, vol. 50, no. 5, pp. 1021–1029, 2001. View at Google Scholar · View at Scopus
  137. J. Kuhlmann, C. Neumann-Haefelin, U. Belz et al., “Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats,” Diabetes, vol. 52, no. 1, pp. 138–144, 2003. View at Publisher · View at Google Scholar · View at Scopus
  138. M. A. Potenza, F. L. Marasciulo, D. M. Chieppa et al., “Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production,” American Journal of Physiology, vol. 289, no. 2, pp. H813–H822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  139. T. J. Aitman, A. M. Glazier, C. A. Wallace et al., “Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats,” Nature Genetics, vol. 21, no. 1, pp. 76–83, 1999. View at Publisher · View at Google Scholar · View at Scopus
  140. V. A. Lira, Q. A. Soltow, J. H. D. Long, J. L. Betters, J. E. Sellman, and D. S. Criswell, “Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle,” American Journal of Physiology, vol. 293, no. 4, pp. E1062–E1068, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. T. Yamauchi, J. Kamon, Y. Minokoshi et al., “Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase,” Nature Medicine, vol. 8, no. 11, pp. 1288–1295, 2002. View at Publisher · View at Google Scholar · View at Scopus
  142. Z. Guo, Z. Xia, V. G. Yuen, and J. H. McNeill, “Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats,” Metabolism, vol. 56, no. 10, pp. 1363–1371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  143. D. Q. Shih, M. Heimesaat, S. Kuwajima, R. Stein, C. V. E. Wright, and M. Stoffel, “Profound defects in pancreatic β-cell function in mice with combined heterozygous mutations in Pdx-1, Hnf-1α, and Hnf-3β,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 6, pp. 3818–3823, 2002. View at Publisher · View at Google Scholar · View at Scopus
  144. B. F. Holmes, D. P. Sparling, A. L. Olson, W. W. Winder, and G. L. Dohm, “Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase,” American Journal of Physiology, vol. 289, no. 6, pp. E1071–E1076, 2005. View at Publisher · View at Google Scholar · View at Scopus
  145. R. Song, M. Kubo, D. Morse et al., “Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects,” American Journal of Pathology, vol. 163, no. 1, pp. 231–242, 2003. View at Google Scholar · View at Scopus
  146. J. Janke, S. Engeli, K. Gorzelniak, F. C. Luft, and A. M. Sharma, “Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors,” Diabetes, vol. 51, no. 6, pp. 1699–1707, 2002. View at Google Scholar · View at Scopus
  147. Y. Hattori, K. Akimoto, S. S. Gross, S. Hattori, and K. Kasai, “Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats,” Diabetologia, vol. 48, no. 6, pp. 1066–1074, 2005. View at Publisher · View at Google Scholar · View at Scopus
  148. J. F. Ndisang and R. Wang, “Age-related alterations in soluble guanylyl cyclase and cGMP pathway in spontaneously hypertensive rats,” Journal of Hypertension, vol. 21, no. 6, pp. 1117–1124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  149. J. F. W. L. Ndisang, X. Wang, and R. Wang, “A nine-month antihypertensive effect of hemin opens a new horizon in the fight against hypertension,” in Proceedings of the Experimental Biology Meeting, p. A498, San Diego, Calif, USA, 2005.
  150. A. Jadhav and J. F. Ndisang, “Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension,” Experimental Biology and Medicine, vol. 234, no. 7, pp. 764–778, 2009. View at Publisher · View at Google Scholar · View at Scopus
  151. A. Jadhav, E. Torlakovic, and J. F. Ndisang, “Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats,” American Journal of Physiology, vol. 296, no. 3, pp. F521–F534, 2009. View at Publisher · View at Google Scholar · View at Scopus
  152. N. G. Abraham and A. Kappas, “Heme oxygenase and the cardiovascular-renal system,” Free Radical Biology and Medicine, vol. 39, no. 1, pp. 1–25, 2005. View at Publisher · View at Google Scholar · View at Scopus
  153. T. Aizawa, N. Ishizaka, J.-I. Taguchi et al., “Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection,” Hypertension, vol. 35, no. 3, pp. 800–806, 2000. View at Google Scholar · View at Scopus
  154. F. K. Johnson, W. Durante, K. J. Peyton, and R. A. Johnson, “Heme oxygenase-mediated endothelial dysfunction in DOCA-salt, but not in spontaneously hypertensive, rat arterioles,” American Journal of Physiology, vol. 286, no. 5, pp. H1681–H1687, 2004. View at Publisher · View at Google Scholar · View at Scopus
  155. N. K. C. Lima, F. Abbasi, C. Lamendola, and G. M. Reaven, “Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension,” American Journal of Hypertension, vol. 22, no. 1, pp. 106–111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  156. J. García-Puig, L. M. Ruilope, M. Luque, J. Fernández, R. Ortega, and R. Dal-Ré, “Glucose metabolism in patients with essential hypertension,” American Journal of Medicine, vol. 119, no. 4, pp. 318–326, 2006. View at Publisher · View at Google Scholar · View at Scopus
  157. C. Catena, R. Lapenna, S. Baroselli et al., “Insulin sensitivity in patients with primary aldosteronism: a follow-up study,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 9, pp. 3457–3463, 2006. View at Publisher · View at Google Scholar · View at Scopus
  158. G. Giacchetti, V. Ronconi, F. Turchi et al., “Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study,” Journal of Hypertension, vol. 25, no. 1, pp. 177–186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  159. F. Fallo, F. Veglio, C. Bertello et al., “Prevalence and characteristics of the metabolic syndrome in primary aldosteronism,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 2, pp. 454–459, 2006. View at Publisher · View at Google Scholar · View at Scopus
  160. Y. Lavrovsky, M. L. Schwartzman, R. D. Levere, A. Kappas, and N. G. Abraham, “Identification of binding sites for transcription factors NF-κB and AP-2 in the promoter region of the human heme oxygenase 1 gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 13, pp. 5987–5991, 1994. View at Publisher · View at Google Scholar · View at Scopus
  161. Y. Lavrovsky, C. S. Song, B. Chatterjee, and A. K. Roy, “Age-dependent increase of heme oxygenase-1 gene expression in the liver mediated by NFκB,” Mechanisms of Ageing and Development, vol. 114, no. 1, pp. 49–60, 2000. View at Publisher · View at Google Scholar · View at Scopus
  162. T. Sasaki, T. Takahashi, H. Shimizu et al., “Heme arginate pretreatment attenuates pulmonary NF-?B and AP-1 activation induced by hemorrhagic shock via heme oxygenase-1 induction,” Medicinal Chemistry, vol. 2, no. 3, pp. 271–274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  163. S. Shibahara, M. Nakayama, T. Kitamuro, R. Udono-Fujimori, and K. Takahashi, “Repression of heme oxygenase-1 expression as a defense strategy in humans,” Experimental Biology and Medicine, vol. 228, no. 5, pp. 472–473, 2003. View at Google Scholar · View at Scopus
  164. S. W. Chung, X. Liu, A. A. Macias, R. M. Baron, and M. A. Perrella, “Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice,” Journal of Clinical Investigation, vol. 118, no. 1, pp. 239–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  165. M. D. Maines and N. Panahian, “The heme oxygenase system and cellular defense mechanisms: do HO-1 and HO-2 have different functions?” Advances in Experimental Medicine and Biology, vol. 502, pp. 249–272, 2001. View at Google Scholar · View at Scopus
  166. L. E. Otterbein and A. M. K. Choi, “Heme oxygenase: colors of defense against cellular stress,” American Journal of Physiology, vol. 279, no. 6, pp. L1029–L1037, 2000. View at Google Scholar
  167. M. Delhase, M. Hayakawa, Y. Chen, and M. Karin, “Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation,” Science, vol. 284, no. 5412, pp. 309–313, 1999. View at Google Scholar · View at Scopus
  168. J. Tsai, R. Zhang, W. Qiu, Q. Su, M. Naples, and K. Adeli, “Inflammatory NF-κB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production,” American Journal of Physiology, vol. 296, no. 6, pp. G1287–G1298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  169. K. J. Ladner, M. A. Caligiuri, and D. C. Guttridge, “Tumor necrosis factor-regulated biphasic activation of NF-κB is required for cytokine-induced loss of skeletal muscle gene products,” The Journal of Biological Chemistry, vol. 278, no. 4, pp. 2294–2303, 2003. View at Publisher · View at Google Scholar · View at Scopus
  170. H. Buss, A. Dorrie, M. L. Schmitz, E. Hoffmann, K. Resch, and M. Kracht, “Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription,” The Journal of Biological Chemistry, vol. 279, no. 53, pp. 55633–55643, 2004. View at Publisher · View at Google Scholar · View at Scopus
  171. P. A. Baeuerle and D. Baltimore, “Nf-κB: ten years after,” Cell, vol. 87, no. 1, pp. 13–20, 1996. View at Publisher · View at Google Scholar · View at Scopus
  172. D. M. Rothwarf and M. Karin, “The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus,” Science's STKE, vol. 1999, no. 5, p. RE1, 1999. View at Google Scholar
  173. M. C. Arkan, A. L. Hevener, F. R. Greten et al., “IKK-ß links inflammation to obesity-induced insulin resistance,” Nature Medicine, vol. 11, no. 2, pp. 191–198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  174. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes,” Endocrine Reviews, vol. 23, no. 5, pp. 599–622, 2002. View at Publisher · View at Google Scholar · View at Scopus
  175. C. A. de la Lastra, S. Sanchez-Fidalgo, I. Villegas, and V. Motilva, “New pharmacological perspectives and therapeutic potential of PPAR-γ agonists,” Current Pharmaceutical Design, vol. 10, no. 28, pp. 3505–3524, 2004. View at Publisher · View at Google Scholar · View at Scopus
  176. R. Henningsson, P. Alm, and I. Lundquist, “Evaluation of islet heme oxygenase-CO and nitric oxide synthase-NO pathways during acute endotoxemia,” American Journal of Physiology, vol. 280, no. 5, pp. C1242–C1254, 2001. View at Google Scholar · View at Scopus
  177. K. E. Wellen and G. S. Hotamisligil, “Inflammation, stress, and diabetes,” Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111–1119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  178. J. Hirosumi, G. Tuncman, L. Chang et al., “A central, role for JNK in obesity and insulin resistance,” Nature, vol. 420, no. 6913, pp. 333–336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  179. Y. Nakatani, H. Kaneto, D. Kawamori et al., “Modulation of the JNK pathway in liver affects insulin resistance status,” The Journal of Biological Chemistry, vol. 279, no. 44, pp. 45803–45809, 2004. View at Publisher · View at Google Scholar · View at Scopus
  180. R. Yang, D. M. Wilcox, D. L. Haasch et al., “Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor ? coactivator 1ß and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese mice,” The Journal of Biological Chemistry, vol. 282, no. 31, pp. 22765–22774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  181. H. Kaneto, Y. Nakatani, T. Miyatsuka et al., “Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide,” Nature Medicine, vol. 10, no. 10, pp. 1128–1132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  182. G. Liu and C. M. Rondinone, “JNK: bridging the insulin signaling and inflammatory pathway,” Current Opinion in Investigational Drugs, vol. 6, no. 10, pp. 979–987, 2005. View at Google Scholar · View at Scopus
  183. M. A. Bogoyevitch and P. G. Arthur, “Inhibitors of c-Jun N-terminal kinases-JuNK no more?” Biochimica et Biophysica Acta, vol. 1784, no. 1, pp. 76–93, 2008. View at Publisher · View at Google Scholar · View at Scopus
  184. L. C. de la Rosa, T. E. Vrenken, R. A. Hannivoort et al., “Carbon monoxide blocks oxidative stress-induced hepatocyte apoptosis via inhibition of the p54 JNK isoform,” Free Radical Biology and Medicine, vol. 44, no. 7, pp. 1323–1333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  185. D. M. L. Tsukumo, M. A. Carvalho-Filho, J. B. C. Carvalheira et al., “Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance,” Diabetes, vol. 56, no. 8, pp. 1986–1998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  186. M. J. Song, K. H. Kim, J. M. Yoon, and J. B. Kim, “Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes,” Biochemical and Biophysical Research Communications, vol. 346, no. 3, pp. 739–745, 2006. View at Publisher · View at Google Scholar · View at Scopus
  187. O. Hamdy, S. Porramatikul, and E. Al-Ozairi, “Metabolic obesity: the paradox between visceral and subcutaneous fat,” Current Diabetes Reviews, vol. 2, no. 4, pp. 367–373, 2006. View at Google Scholar · View at Scopus
  188. F. Garcia Soriano, L. Virag, P. Jagtap et al., “Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation,” Nature Medicine, vol. 7, no. 1, pp. 108–113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  189. M. Morigi, S. Angioletti, B. Imberti et al., “Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion,” Journal of Clinical Investigation, vol. 101, no. 9, pp. 1905–1915, 1998. View at Google Scholar · View at Scopus
  190. A. S. Dias, M. Porawski, M. Alonso, N. Marroni, P. S. Collado, and J. Gonzalez-Gallego, “Quercetin decreases oxidative stress, NF-κB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats,” Journal of Nutrition, vol. 135, no. 10, pp. 2299–2304, 2005. View at Google Scholar · View at Scopus
  191. S. I. Itani, N. B. Ruderman, F. Schmieder, and G. Boden, “Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α,” Diabetes, vol. 51, no. 7, pp. 2005–2011, 2002. View at Google Scholar · View at Scopus
  192. R. S. Ahima, “Connecting obesity, aging and diabetes,” Nature Medicine, vol. 15, no. 9, pp. 996–997, 2009. View at Publisher · View at Google Scholar · View at Scopus
  193. T. Minamino, M. Orimo, I. Shimizu et al., “A crucial role for adipose tissue p53 in the regulation of insulin resistance,” Nature Medicine, vol. 15, no. 9, pp. 1082–1087, 2009. View at Publisher · View at Google Scholar · View at Scopus
  194. G. P. Chrousos and P. W. Gold, “The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis,” Journal of the American Medical Association, vol. 267, no. 9, pp. 1244–1252, 1992. View at Publisher · View at Google Scholar · View at Scopus
  195. J. Q. Purnell, S. E. Kahn, M. H. Samuels, D. Brandon, D. L. Loriaux, and J. D. Brunzell, “Enhanced cortisol production rates, free cortisol, and 11β-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss,” American Journal of Physiology, vol. 296, no. 2, pp. E351–E357, 2009. View at Publisher · View at Google Scholar · View at Scopus
  196. J. R. Seckl and B. R. Walker, “Minireview: 11β-hydroxysteroid dehydrogenase type 1—a tissue-specific amplifier of glucocorticoid action,” Endocrinology, vol. 142, no. 4, pp. 1371–1376, 2001. View at Publisher · View at Google Scholar · View at Scopus
  197. Y. Kotelevtsev, M. C. Holmes, A. Burchell et al., “11ß-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 26, pp. 14924–14929, 1997. View at Publisher · View at Google Scholar · View at Scopus
  198. N. M. Morton, M. C. Holmes, C. Fievet et al., “Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11ß-hydroxysteroid dehydrogenase type 1 null mice,” The Journal of Biological Chemistry, vol. 276, no. 44, pp. 41293–41300, 2001. View at Publisher · View at Google Scholar · View at Scopus
  199. H. Masuzaki, J. Paterson, H. Shinyama et al., “A transgenic model of visceral obesity and the metabolic syndrome,” Science, vol. 294, no. 5549, pp. 2166–2170, 2001. View at Publisher · View at Google Scholar · View at Scopus
  200. S. Engeli, J. Bohnke, M. Feldpausch et al., “Regulation of 11ß-HSD genes in human adipose tissue: influence of central obesity and weight loss,” Obesity Research, vol. 12, pp. 9–17, 2004. View at Google Scholar · View at Scopus
  201. G. Valsamakis, A. Anwar, J. W. Tomlinson et al., “11ß-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 9, pp. 4755–4761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  202. S. Shakeri-Manesch, M. Zeyda, J. Huber, B. Ludvik, G. Prager, and T. M. Stulnig, “Diminished upregulation of visceral adipose heme oxygenase-1 correlates with waist-to-hip ratio and insulin resistance,” International Journal of Obesity, vol. 33, no. 11, pp. 1257–1264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  203. J. F. Ndisang, A. Jadhav, and N. Lane, “Interaction between the heme oxygenase system and aldosterone in hypertension,” International Journal of Angiology, vol. 16, pp. 92–97, 2007. View at Google Scholar
  204. C. N. Lumeng, J. B. Delproposto, D. J. Westcott, and A. R. Saltiel, “Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes,” Diabetes, vol. 57, no. 12, pp. 3239–3246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  205. J. I. Odegaard, R. R. Ricardo-Gonzalez, M. H. Goforth et al., “Macrophage-specific PPAR? controls alternative activation and improves insulin resistance,” Nature, vol. 447, no. 7148, pp. 1116–1120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  206. S. Gordon, “Alternative activation of macrophages,” Nature Reviews Immunology, vol. 3, no. 1, pp. 23–35, 2003. View at Publisher · View at Google Scholar · View at Scopus
  207. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., “Obesity is associated with macrophage accumulation in adipose tissue,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  208. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  209. H. Tao, S. Aakula, N. N. Abumrad, and T. Hajri, “Peroxisome proliferator-activated receptor-γ regulates the expression and function of very-low-density lipoprotein receptor,” American Journal of Physiology, vol. 298, no. 1, pp. E68–E79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  210. T. Kawai, T. Masaki, S. Doi et al., “PPAR-? agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-ß,” Laboratory Investigation, vol. 89, no. 1, pp. 47–58, 2009. View at Publisher · View at Google Scholar · View at Scopus
  211. R. Pakala, P. Kuchulakanti, S.-W. Rha, E. Cheneau, R. Baffour, and R. Waksman, “Peroxisome proliferator-activated receptor γ: its role in metabolic syndrome,” Cardiovascular Radiation Medicine, vol. 5, no. 2, pp. 97–103, 2004. View at Publisher · View at Google Scholar · View at Scopus
  212. D. E. Moller and J. P. Berger, “Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation,” International Journal of Obesity, vol. 27, supplement 3, pp. S17–S21, 2003. View at Publisher · View at Google Scholar · View at Scopus
  213. L. Fajas, M.-B. Debril, and J. Auwerx, “PPARγ: an essential role in metabolic control,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 11, no. 1, pp. 64–69, 2001. View at Google Scholar · View at Scopus
  214. J. Ma, C. K. Lau, A. Obed et al., “A cell penetrating heme oxygenase protein protects heart graft against ischemia/reperfusion injury,” Gene Therapy, vol. 16, no. 3, pp. 320–328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  215. G. Kronke, A. Kadl, E. Ikonomu et al., “Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 6, pp. 1276–1282, 2007. View at Publisher · View at Google Scholar · View at Scopus
  216. A. V. Finn, M. John, G. Nakazawa et al., “Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor ? agonists: requirement for mTOR/Akt2 in PPAR? activation,” Circulation Research, vol. 105, no. 10, pp. 1003–1012, 2009. View at Publisher · View at Google Scholar · View at Scopus
  217. H. E. Ferguson, T. H. Thatcher, K. C. Olsen et al., “Peroxisome proliferator-activated receptor-? ligands induce heme oxygenase-1 in lung fibroblasts by a PPAR?-independent, glutathione-dependent mechanism,” American Journal of Physiology, vol. 297, no. 5, pp. L912–L919, 2009. View at Publisher · View at Google Scholar · View at Scopus
  218. M. Bilban, P. Haslinger, J. Prast et al., “Identification of novel trophoblast invasion-related genes: heme oxygenase-1 controls motility via peroxisome proliferator-activated receptor ?,” Endocrinology, vol. 150, no. 2, pp. 1000–1013, 2009. View at Publisher · View at Google Scholar · View at Scopus
  219. S. C. Griffen, J. Wang, and M. S. German, “A genetic defect in β-cell gene expression segregates independently from the fa locus in the ZDF rat,” Diabetes, vol. 50, no. 1, pp. 63–68, 2001. View at Google Scholar · View at Scopus
  220. J. F. Ndisang, N. Lane, and A. Jadhav, “The heme oxygenase system abates hyperglycaemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways,” Endocrinology, vol. 151, no. 2, pp. 549–560, 2010. View at Google Scholar
  221. N. Houstis, E. D. Rosen, and E. S. Lander, “Reactive oxygen species have a causal role in multiple forms of insulin resistance,” Nature, vol. 440, no. 7086, pp. 944–948, 2006. View at Publisher · View at Google Scholar · View at Scopus
  222. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Are oxidative stress—activated signaling pathways mediators of insulin resistance and β-cell dysfunction?” Diabetes, vol. 52, no. 1, pp. 1–8, 2003. View at Publisher · View at Google Scholar · View at Scopus
  223. R. Vinayagamoorthi, Z. Bobby, and M. G. Sridhar, “Antioxidants preserve redox balance and inhibit c-Jun-N-terminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and insulin resistance,” Journal of Endocrinology, vol. 197, no. 2, pp. 287–296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  224. A. D. Baron and M. G. Clark, “Role of blood flow in the regulation of muscle glucose uptake,” Annual Review of Nutrition, vol. 17, pp. 487–499, 1997. View at Publisher · View at Google Scholar · View at Scopus
  225. W. A. Pryor and G. L. Squadrito, “The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide,” American Journal of Physiology, vol. 268, no. 5, pp. L699–L722, 1995. View at Google Scholar
  226. S. A. Ritchie, C. F. Kohlhaas, A. R. Boyd et al., “Insulin-stimulated phosphorylation of endothelial nitric oxide synthase at serine-615 contributes to nitric oxide synthesis,” Biochemical Journal, vol. 426, no. 1, pp. 85–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  227. H. P. Kim, S. W. Ryter, and A. M. K. Choi, “CO as a cellular signaling molecule,” Annual Review of Pharmacology and Toxicology, vol. 46, pp. 411–449, 2006. View at Publisher · View at Google Scholar · View at Scopus
  228. A. Loboda, A. Jazwa, A. Grochot-Przeczek et al., “Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities,” Antioxidants and Redox Signaling, vol. 10, no. 10, pp. 1767–1812, 2008. View at Publisher · View at Google Scholar · View at Scopus
  229. D. E. Stec, T. Vera, G. R. McLemore Jr. et al., “Heme oxygenase-1 induction does not improve vascular relaxation in angiotensin II hypertensive mice,” American Journal of Hypertension, vol. 21, no. 2, pp. 189–193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  230. J. F. Ndisang and R. Wang, “Novel therapeutic strategies for impaired endothelium-dependent vascular relaxation,” Expert Opinion on Therapeutic Patents, vol. 12, no. 8, pp. 1237–1247, 2002. View at Publisher · View at Google Scholar · View at Scopus
  231. N. Kobayashi, S.-I. Mita, K. Yoshida et al., “Celiprolol activates eNOS through the PI3K-Akt pathway and inhibits VCAM-1 Via NF-?B induced by oxidative stress,” Hypertension, vol. 42, no. 5, pp. 1004–1013, 2003. View at Publisher · View at Google Scholar · View at Scopus
  232. J. R. Sowers, “Insulin resistance and hypertension,” American Journal of Physiology, vol. 286, no. 5, pp. H1597–H1602, 2004. View at Publisher · View at Google Scholar · View at Scopus
  233. R. Nistala and C. S. Stump, “Skeletal muscle insulin resistance is fundamental to the cardiometabolic syndrome,” Journal of the cardiometabolic syndrome, vol. 1, no. 1, pp. 47–52, 2006. View at Publisher · View at Google Scholar · View at Scopus
  234. F. El-Atat, A. Aneja, S. Mcfarlane, and J. Sowers, “Obesity and hypertension,” Endocrinology and Metabolism Clinics of North America, vol. 32, no. 4, pp. 823–854, 2003. View at Publisher · View at Google Scholar · View at Scopus
  235. M. Diamant and M. E. Tushuizen, “The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD?” Current Diabetes Reports, vol. 6, no. 4, pp. 279–286, 2006. View at Publisher · View at Google Scholar · View at Scopus
  236. S. Addison, S. Stas, M. R. Hayden, and J. R. Sowers, “Insulin resistance and blood pressure,” Current Hypertension Reports, vol. 10, no. 4, pp. 319–325, 2008. View at Publisher · View at Google Scholar · View at Scopus
  237. M. S. Rendell and L. Jovanovic, “Targeting postprandial hyperglycemia,” Metabolism, vol. 55, no. 9, pp. 1263–1281, 2006. View at Publisher · View at Google Scholar · View at Scopus
  238. P. Song, Y. Wu, J. Xu et al., “Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent manner,” Circulation, vol. 116, no. 14, pp. 1585–1595, 2007. View at Publisher · View at Google Scholar · View at Scopus
  239. C. Tang, P. Han, A. I. Oprescu et al., “Evidence for a role of superoxide generation in glucose-induced ß-cell dysfunction in vivo,” Diabetes, vol. 56, no. 11, pp. 2722–2731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  240. H. Kaneto, T.-A. Matsuoka, N. Katakami et al., “Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes,” Current Molecular Medicine, vol. 7, no. 7, pp. 674–686, 2007. View at Publisher · View at Google Scholar · View at Scopus
  241. S. Lenzen, “Oxidative stress: the vulnerable β-cell,” Biochemical Society Transactions, vol. 36, no. 3, pp. 343–347, 2008. View at Publisher · View at Google Scholar · View at Scopus
  242. E. Devangelio, F. Santilli, G. Formoso et al., “Soluble RAGE in type 2 diabetes: association with oxidative stress,” Free Radical Biology and Medicine, vol. 43, no. 4, pp. 511–518, 2007. View at Publisher · View at Google Scholar · View at Scopus
  243. R. P. Robertson, J. Harmon, P. O. T. Tran, and V. Poitout, “β-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes,” Diabetes, vol. 53, supplement 1, pp. S119–S124, 2004. View at Google Scholar · View at Scopus
  244. J. G. Mabley, G. J. Southan, A. L. Salzman, and C. Szabo, “The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro,” Pancreas, vol. 28, no. 2, pp. E39–E44, 2004. View at Google Scholar · View at Scopus
  245. J. R. Sowers and E. D. Frohlich, “Insulin and insulin resistance: impact on blood pressure and cardiovascular disease,” Medical Clinics of North America, vol. 88, no. 1, pp. 63–82, 2004. View at Publisher · View at Google Scholar · View at Scopus
  246. M. H. Schutta, “Diabetes and hypertension: epidemiology of the relationship and pathophysiology of factors associated with these comorbid conditions,” Journal of the Cardiometabolic Syndrome, vol. 2, no. 2, pp. 124–130, 2007. View at Publisher · View at Google Scholar · View at Scopus
  247. P. Geraldes, K. Yagi, Y. Ohshiro et al., “Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/phosphoinositide 3-kinase/Akt-2 pathway,” The Journal of Biological Chemistry, vol. 283, no. 49, pp. 34327–34336, 2008. View at Publisher · View at Google Scholar · View at Scopus
  248. J.-T. Hsu, W.-H. Kan, C.-H. Hsieh, M. A. Choudhry, K. I. Bland, and I. H. Chaudry, “Mechanism of salutary effects of estrogen on cardiac function following trauma-hemorrhage: Akt-dependent HO-1 up-regulation,” Critical Care Medicine, vol. 37, no. 8, pp. 2338–2344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  249. Y. P. Hwang and H. G. Jeong, “Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells,” Toxicology and Applied Pharmacology, vol. 242, no. 1, pp. 18–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  250. K. C. Kim, K. A. Kang, R. Zhang et al., “Up-regulation of Nrf2-mediated heme oxygenase-1 expression by eckol, a phlorotannin compound, through activation of Erk and PI3K/Akt,” International Journal of Biochemistry and Cell Biology, vol. 42, no. 2, pp. 297–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  251. Y. P. Hwang and H. G. Jeong, “The coffee diterpene kahweol induces heme oxygenase-1 via the PI3K and p38/Nrf2 pathway to protect human dopaminergic neurons from 6-hydroxydopamine-derived oxidative stress,” FEBS Letters, vol. 582, no. 17, pp. 2655–2662, 2008. View at Publisher · View at Google Scholar · View at Scopus